Oji Pharma
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
Oji Pharma is a subsidiary of Oji Holdings, the 7th largest global pulp and paper company and the first-place company in Japan (consolidated sales: $11,308.45M USD, consolidated operating income: $484.00M USD, in 2023). Since Oji Holding is aggressively trying to establish a new business pillar by leveraging its capital and R&D expertise, Oji Pharma is in a position to be an important healthcare business.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}